Navigation Links
Genomatix takes a lead in Next Generation Sequencing

Genomatix is a company with a renowned track record in the analysis of genomic data generated by high throughput technologies. Genomatix algorithms include optimized fast mapping strategies and Genomatix already provides the most complete genome annotation in terms of transcriptome and promoters available in its ElDorado database surpassing alternative databases in this specific content by a factor of 2 to 4.

Pilot studies in collaboration with customers, successfully analyzing Next Generation Sequencing data (from 454 and Solexa) have firmly established that ElDorado brings a dramatic advantage to NGS data processing and interpretation, providing additional information about the transcriptome and its regulation. Result data can be visualized by ElDorado in the full genomic annotation context and a variety of correlation studies and further downstream analyses are possible using other established Genomatix services.

Genomatix announces today that services for NGS studies are available within our consulting model, effective immediately, including Digital Gene Expression (DGE) Studies as well as Chip Sequencing (ChiPSeq) Assays. Inquiries are welcome.


Contact: Peter Grant
Genomatix Software GmbH

Page: 1

Related medicine news :

1. NIH/NCI renews and extends nationwide license for Genomatix software and databases
2. Sanofi-Aventis renews licenses for Genomatix chip analysis pipeline
3. Free will takes flight: how our brains respond to an approaching menace
4. New AHIP Report Takes a Ten Year Look at the Unintended Consequences of State Efforts to Change the Insurance Market
5. Sun Safety Outreach to Families Takes Flight at the Plano Hot Air Balloon Festival
6. Small Army Takes on Cure for Diabetes and New Approach to Ending World Poverty with Addition of Non-Profit Accounts
7. Small Town Doctor Takes on Giants in Consumer Healthcare
8. Help is Available for Smokers Who Want to Quit as Minnesotas Smoke-Free Law Takes Effect Oct. 1
9. Growing Healthy with School Gardens Takes Root in Los Angeles Saturday
10. Randy Jackson Takes Aim at Diabetes
11. New Hampshire: 1st in the Nation Primary State Takes a Stand on E-Prescribing
Post Your Comments:
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: